Results 1 to 10 of about 24,516,016 (295)
Treatment update for autoimmune/immune-mediated central nervous system diseases
Folia NeuropathologicaAutoimmune/immune-mediated central nervous system (CNS) diseases are chronic, inflammatory, autoimmune diseases, such as multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), and autoimmune encephalitis (AE).
Jiayi Wu +5 more
doaj +2 more sources
Frontiers in NeurologyBackgroundNontraumatic subarachnoid hemorrhage (SAH) is a critical condition requiring prolonged hospitalization and significant healthcare costs. Identifying factors contributing to extended length of stay (LOS) and predicting associated hospital ...
Di Wu +13 more
doaj +1 more source
Biomarkers in autoimmune diseases of the central nervous system
Frontiers in Immunology, 2023 The autoimmune diseases of the central nervous system (CNS) represent individual heterogeneity with different disease entities. Although clinical and imaging features make it possible to characterize larger patient cohorts, they may not provide ...
Fenghe Zhang +4 more
doaj +1 more source
Histopathological Frequency of Central Nervous System Diseases
Annals of Abbasi Shaheed Hospital and Karachi Medical & Dental CollegeObjective: To determine the frequency of central nervous system diseases, both neoplastic and nonneoplastic, by methodically examining data from various age and gender groups.
Prih Bashir +5 more
doaj +1 more source
Immunopathogenesis of infectious-inflammatory diseases of central nervous system
Журнал инфектологии, 2014 The revue includes the contemporary information about the role of resident cells of the CNS (astrocytes, microglia) in development of innate immune response against pathogen (or its products) invasion in the brain.
G. F. Zheleznikova, N. V. Skripchenko
doaj +1 more source
Inflammatory Disease of the Central Nervous System
Veterinary Clinics of North America: Small Animal Practice, 1988 Inflammatory diseases involving the central nervous system can be difficult to diagnose and frustrating to treat. The clinician can maximize successful treatment of these patients by recognizing the clinical signs in the early stages of disease, following a logical diagnostic plan to identify the specific etiologic agent involved, and formulating an ...
openaire +2 more sources
Hydrazine-mediated carbonyl–alkyne/allene reductive olefination
Nature CommunicationsCycloolefin is a privileged motif with significant implications across multiple disciplines. While cycloolefination represents the most unified disconnection strategy, the corresponding approaches are notably scarce.
Linjun Qi +4 more
doaj +1 more source
Frontiers in EndocrinologyBackgroundMetabolic dysfunction-associated steatotic liver disease (MASLD) is highly prevalent in type 2 diabetes mellitus (T2DM) and amplifies cardiovascular and metabolic burden.
Fengtong Zuo, XiaoYan Wang, Changan Xu
doaj +1 more source
The complement system in central nervous system diseases
Autoimmunity, 2006 The activation of complement system is important factor in inflammatory, neurodegenerative and cerebrovascular diseases. CNS cells are able to synthesize complement components, and myelin and oligodendrocytes (OLG) are known to activate the classical pathway of complement in vitro in the absence of antibodies.
Horea, Rus +3 more
openaire +2 more sources
Microphysiological Systems for Neurodegenerative Diseases in Central Nervous System
Micromachines, 2020 Neurodegenerative diseases are among the most severe problems in aging societies. Various conventional experimental models, including 2D and animal models, have been used to investigate the pathogenesis of (and therapeutic mechanisms for ...
Mihyeon Bae +3 more
doaj +1 more source